Compass Therapeutics (CMPX) Treasury Shares (2018 - 2026)

Compass Therapeutics (CMPX) has 9 years of Treasury Shares data on file, last reported at $1.6 million in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares fell 45.43% year-over-year to $1.6 million; the trailing twelve-month figure through Mar 2026 stood at $1.6 million (down 45.43% YoY), and the FY2025 full-year result was $1.0 million, down 72.7% from the prior year.
• Treasury Shares improved to $1.6 million in Q1 2026, from $1.0 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $3.8 million in Q4 2024 to a low of $132000.0 in Q1 2023.
• A 5-year average of $2.0 million and a median of $1.6 million in 2026 frame the typical range for Treasury Shares.
• Across the five-year window, Treasury Shares sank 89.0% in 2023 and jumped 2677.27% in 2024, its largest moves.
• Tracing CMPX's Treasury Shares over 5 years: stood at $900000.0 in 2022, then soared by 66.67% to $1.5 million in 2023, then soared by 151.07% to $3.8 million in 2024, then tumbled by 72.7% to $1.0 million in 2025, then jumped by 56.23% to $1.6 million in 2026.
• Business Quant data shows CMPX's Treasury Shares at $1.6 million in Q1 2026, $1.0 million in Q4 2025, and $1.3 million in Q3 2025.